Pao Novatek Stock Cash And Equivalents
| NSTKFDelisted Stock | USD 22.29 0.00 0.00% |
PAO NOVATEK fundamentals help investors to digest information that contributes to PAO NOVATEK's financial success or failures. It also enables traders to predict the movement of PAO Pink Sheet. The fundamental analysis module provides a way to measure PAO NOVATEK's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PAO NOVATEK pink sheet.
PAO |
PAO NOVATEK Company Cash And Equivalents Analysis
PAO NOVATEK's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current PAO NOVATEK Cash And Equivalents | 107.68 B |
Most of PAO NOVATEK's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PAO NOVATEK is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, PAO NOVATEK has 107.68 B in Cash And Equivalents. This is much higher than that of the Energy sector and significantly higher than that of the Oil & Gas E&P industry. The cash and equivalents for all United States stocks is significantly lower than that of the firm.
PAO Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PAO NOVATEK's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PAO NOVATEK could also be used in its relative valuation, which is a method of valuing PAO NOVATEK by comparing valuation metrics of similar companies.PAO NOVATEK is currently under evaluation in cash and equivalents category among its peers.
PAO Fundamentals
| Return On Equity | 0.25 | |||
| Return On Asset | 0.0772 | |||
| Profit Margin | 0.41 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 68.11 B | |||
| Shares Outstanding | 3 B | |||
| Shares Owned By Insiders | 41.09 % | |||
| Shares Owned By Institutions | 2.44 % | |||
| Price To Earning | 2.22 X | |||
| Price To Book | 2.16 X | |||
| Price To Sales | 0.06 X | |||
| Revenue | 1.16 T | |||
| Gross Profit | 461.16 B | |||
| EBITDA | 562.38 B | |||
| Net Income | 432.93 B | |||
| Cash And Equivalents | 107.68 B | |||
| Cash Per Share | 358.59 X | |||
| Total Debt | 67.01 B | |||
| Debt To Equity | 0.11 % | |||
| Current Ratio | 2.66 X | |||
| Book Value Per Share | 6,324 X | |||
| Cash Flow From Operations | 419.47 B | |||
| Earnings Per Share | 2.35 X | |||
| Number Of Employees | 10 | |||
| Beta | -33.61 | |||
| Market Capitalization | 66.78 B | |||
| Total Asset | 2.46 T | |||
| Annual Yield | 0.07 % | |||
| Net Asset | 2.46 T | |||
| Last Dividend Paid | 714.4 |
About PAO NOVATEK Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PAO NOVATEK's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PAO NOVATEK using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PAO NOVATEK based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in PAO Pink Sheet
If you are still planning to invest in PAO NOVATEK check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PAO NOVATEK's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |